medigraphic.com

2021, Number 2

<< Back Next >>

Rev Mex Anest 2021; 44 (2)

Myocardial injury in the perioperative period of non-cardiac surgery

Luna-Ortiz P, Bernal-Ríos N, García-Bravo M, Fortis-Olmedo LL, Martínez-Rosas M

Language: Spanish
References: 38
Page: 123-129
PDF size: 339.11 Kb.


ABSTRACT

Recent studies on the death causes in the postoperative period of non-cardiac surgery have identified myocardial injury as a complication that is associated with major adverse cardiac events that increase mortality at 30 days after surgery. This kind of myocardial lesion is characterized by the elevation of the cardiac troponins levels during or in the 30 days after the surgery, without symptoms ischemia or changes in the electrocardiogram. Currently, one main goal has been the timely diagnosis of this complication, besides preventive therapies development. The present review article examines the current body of knowledge of this injury, the physiopathological mechanisms and its management.


REFERENCES

  1. Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015; 385: S11.

  2. Group PS. Devereaux PJ, Yang H, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371: 1839-1847.

  3. Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494-1503.

  4. Smilowitz NR, Berger JS. Perioperative management to reduce cardiovascular events. Circulation. 2016;133:1125-1130.

  5. Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258-2269.

  6. Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295-2304.

  7. Semel ME, Lipsitz SR, Funk LM, et al. Rates and patterns of death after surgery in the United States, 1996 and 2006. Surgery. 2012;151:171-182.

  8. Ekeloef S, Alamili M, Devereaux PJ, et al. Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis. Br J Anaesth. 2016;117:559-568.

  9. Landesberg G, Shatz V, Akopnik I, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery J Am Coll Cardiol. 2003;42:1547-1554

  10. Kim LJ, Martínez EA, Faraday N, et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation. 2002;106:2366-2371.

  11. Biccard BM. Detection and management of perioperative myocardial ischemia. Curr Opin Anaesthesiol. 2014;27:336-343.

  12. Devereaux P. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery. Ann Intern Med. 2011;154:523-528.

  13. Feigl EO. Coronary autoregulation. J Hypertens. 1989;7:S55-58.

  14. Klocke FJ. Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation. 1987;76:1183-1189.

  15. López HR, Poblano M, Sánchez C, Aguirre J, Franco J. Parámetros hemodinámicos y el tratamiento de choque como determinantes de la presión de perfusión coronaria (PPC) en el paciente crítico. Rev Asoc Mex Med Crit y Ter Int. 2010;24:119-123.

  16. Cheatham M. Cálculos hemodinámicos. Disponible en www.surgicalcri-ticalcare.net/Lectures/hemodynamic_calculations.pdf2.

  17. Barrera-Ramírez CF, Escaned J. Fisiología coronaria y su utilidad para el cardiólogo intervencionista: Medición invasiva de la presión y flujo coronarios. Arch Cardiol Mex 2005;75:335-349.

  18. Gobel FL, Norstrom LA, Nelson RR, et al. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978;57:549-556.

  19. Sabate S, Mases N, Guilera J, et al. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Brith J Anesth. 2011;107:879-890.

  20. Seller D, Srinivas C, Djaiani G. Cardiovascular complications after non-cardiac surgery. Anesthesia. 2018;73:34-42.

  21. Smilowitz NR, Gupta N, Ramakrishna H, et al. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol. 2017;2:181-187.

  22. Levy M, Heels-Ansdell D, Hiralal R, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology. 2011;114:796-806.

  23. Redfern G, Rodseth RN, Biccard BM. Outcomes in vascular surgical patients with isolated postoperative troponin leak: a meta-analysis. Anaesthesia. 2011;66:604-610.

  24. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581-1598.

  25. Thygesen K, Alpert JS, Jaffe AS, et al. Four universal definition of myocardial infarction. Circulation. 2018;138:e618-e651.

  26. Sandoval Y, Thordsen SE, Smith SW, et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180 day mortaliy risk. Eur Heart J Acute Cardiovasc Care. 2014;3:317-325.

  27. Landesberg G, Beattie WS, Mosseri M, et al. Perioperative myocardial infarction. Circulation. 2009;119:2936-2944.

  28. Gibbs NM, Crawford GP, Michalopoulos N. Postoperative changes in coagulant and anticoagulant factors following abdominal aortic surgery. J Cardiothorac Vasc Anesth. 1992;6:680-685.

  29. Fukumoto Y, Hiro T, Fujii T, et al. Localized elevation of shear stress is related to coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution. J Am Coll Cardiol. 2008;51:645-650.

  30. Landesberg G. The pathophysiology of perioperative myocardial infarction: facts and perspectives. J Cardiothorac Vasc Anesth. 2003;17:90-100.

  31. Sandoval Y, Smith SW, Thordsen SE, et al. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol. 2014;63:2079-2087.

  32. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.

  33. Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation- 2011;124:381-387.

  34. Duceppe E. Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. 2017;33:17-32.

  35. Devereaux PJ, Duceppe E, Guyatt G, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018;391:2325-2334.

  36. Putzu A, de Carvalho E Silva CMPD, de Almeida JP, et al. Perioperative statin therapy in cardiac and non-cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Ann. Intensive Care. 2018;8:2-14.

  37. Torborg A, Ryan L, Kantor G, et al. The pharmaco-economics of routine postoperative troponin surveillance to prevent and treat myocardial infarction after non-cardiac surgery. S Afr Med J. 2014;104:619-623.

  38. Biccard BM. Perioperative myocardial infarction. S Afr J Anesth Analg. 2010;16:44-46.




2020     |     www.medigraphic.com